143 related articles for article (PubMed ID: 8687193)
1. Apolipoprotein E and cognitive change in an elderly population.
Hyman BT; Gomez-Isla T; Briggs M; Chung H; Nichols S; Kohout F; Wallace R
Ann Neurol; 1996 Jul; 40(1):55-66. PubMed ID: 8687193
[TBL] [Abstract][Full Text] [Related]
2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
3. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
4. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E epsilon 4 allele is not associated with the cognitive impairment in community-dwelling normal elderly individuals.
Kim KW; Youn JC; Jhoo JH; Lee DY; Lee KU; Lee JH; Woo JI
Int J Geriatr Psychiatry; 2002 Jul; 17(7):635-40. PubMed ID: 12112161
[TBL] [Abstract][Full Text] [Related]
6. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
[TBL] [Abstract][Full Text] [Related]
7. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype.
Bracco L; Piccini C; Baccini M; Bessi V; Biancucci F; Nacmias B; Bagnoli S; Sorbi S
Dement Geriatr Cogn Disord; 2007; 24(6):483-91. PubMed ID: 18025782
[TBL] [Abstract][Full Text] [Related]
8. Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.
Ewers M; Zhong Z; Bürger K; Wallin A; Blennow K; Teipel SJ; Shen Y; Hampel H
Brain; 2008 May; 131(Pt 5):1252-8. PubMed ID: 18334538
[TBL] [Abstract][Full Text] [Related]
9. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
[TBL] [Abstract][Full Text] [Related]
10. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
11. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
[TBL] [Abstract][Full Text] [Related]
12. The effect of the ApoE genotype on the association between head circumference and cognition.
Kim KR; Lee KS; Kim EA; Cheong HK; Oh BH; Hong CH
Am J Geriatr Psychiatry; 2008 Oct; 16(10):819-25. PubMed ID: 18827228
[TBL] [Abstract][Full Text] [Related]
13. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
Knopman DS; Mosley TH; Catellier DJ; Coker LH;
Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
[TBL] [Abstract][Full Text] [Related]
14. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
15. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
16. Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community.
Manly JJ; Bell-McGinty S; Tang MX; Schupf N; Stern Y; Mayeux R
Arch Neurol; 2005 Nov; 62(11):1739-46. PubMed ID: 16286549
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.
Setzer M; Hermann E; Seifert V; Marquardt G
Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly.
Lee KS; Jang Y; Chung YK; Chung JH; Oh BH; Hong CH
Arch Gerontol Geriatr; 2010; 50(1):69-72. PubMed ID: 19243844
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
[TBL] [Abstract][Full Text] [Related]
20. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
